BeiGene
ONC
#682
Rank
A$45.54 B
Marketcap
$401.36
Share price
2.82%
Change (1 day)
80.93%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Market capitalization of BeiGene (ONC)

Market cap: A$45.54 Billion

As of April 2025 BeiGene has a market cap of A$45.54 Billion. This makes BeiGene the world's 682th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BeiGene from 2016 to 2025

End of year Market Cap

Year Marketcap Change
2025A$45.54 B38.32%
2024A$32.92 B13.79%
2023A$28.93 B-22.58%
2022A$37.37 B-2.51%
2021A$38.33 B24.54%
2020A$30.78 B110.92%
2019A$14.59 B23.01%
2018A$11.86 B108.11%
2017A$5.70 B241.11%
2016A$1.67 B

End of Day market cap according to different sources

On Apr 24th, 2025 the market cap of BeiGene was reported to be:

A$42.83 Billion
by Nasdaq info icon info icon
A$46.68 Billion
by CompaniesMarketCap info icon info icon
A$46.68 Billion
by Yahoo Finance info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
A$32.75 M-99.93%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.81 B-96.02%๐Ÿ‡บ๐Ÿ‡ธ USA